Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis
Daniela Mokrá, Marta Jošková, Juraj Mokrý
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 340-340
Open Access | Times Cited: 101
Ferroptosis: a new hunter of hepatocellular carcinoma
Yulang Jiang, Yongxin Yu, Ziyang Pan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Phytochemicals: a new arsenal in drug discovery
Manal Hatem Ahmed, Saja Ismail Karkush, Sumeia Abbas Ali, et al.
International Journal of Medical Science and Dental Health (2024) Vol. 10, Iss. 01, pp. 29-44
Open Access | Times Cited: 14
Synucleins: New Data on Misfolding, Aggregation and Role in Diseases
Andrei Surguchov, Alexei Surguchev
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3241-3241
Open Access | Times Cited: 41
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials
Stéphanie Andrade, Débora Nunes, Meghna Dabur, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 212-212
Open Access | Times Cited: 21
Phytomedicine for neurodegenerative diseases: The road ahead
Dev Madhubala, Aparup Patra, Mojibur R. Khan, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2993-3019
Closed Access | Times Cited: 8
Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease
Elizabeth Riegelman, Kathy S. Xue, Jia-Sheng Wang, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2041-2041
Open Access | Times Cited: 7
Phytochemicals against Osteoarthritis by Inhibiting Apoptosis
Hui Kong, Juanjuan Han, D.О. Gorbachev, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1487-1487
Open Access | Times Cited: 6
A comparative study of gallic acid and its derivatives on the binding to Keap1 and their ability against 6-hydroxydopamine-induced cytotoxicity
Shengyang Wan, Aiguo Li, Tianbao Dong, et al.
Natural Product Research (2025), pp. 1-8
Closed Access
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
Rubén López-Hernández, María Magdalena de la Torre-Álamo, Borja García‐Bueno, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 121-121
Open Access
Synaptic plasticity and neuroprotection: The molecular impact of flavonoids on neurodegenerative disease progression
Spandana Rajendra Kopalli, Tapan Behl, Ashishkumar Kyada, et al.
Neuroscience (2025)
Closed Access
Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
Yingfan Chen, Zhenhui Wu, Shaodan Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1053-1081
Open Access | Times Cited: 4
Neuroprotective effect of green tea extract (-)-epigallocatechin-3-gallate in a preformed fibril-induced mouse model of Parkinson’s disease
Jianing Shen, Junhua Xie, Liyuan Ye, et al.
Neuroreport (2024) Vol. 35, Iss. 6, pp. 421-430
Open Access | Times Cited: 4
Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms
Mary Dayne Sia Tai, Gloria Gamiz-Arco, Aurora Martı́nez
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1275-1291
Open Access | Times Cited: 4
Protective effects of polyphenol-rich extracts against neurotoxicity elicited by paraquat or rotenone in cellular models of Parkinson’s disease
Mitali A. Tambe, Aurélie de Rus Jacquet, Katherine E. Strathearn, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease
Shi Tang, Yong Zhang, Benson O. A. Botchway, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 2
Innovative mechanisms of micro- and nanoplastic-induced brain injury: Emphasis on the microbiota-gut-brain axis
Liuting Shi, Yuebiao Feng, Jialiang Wang, et al.
Life Sciences (2024) Vol. 357, pp. 123107-123107
Closed Access | Times Cited: 2
Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
Rodrigo Pérez-Arancibia, Marisol Cisternas-Olmedo, Denisse Sepúlveda, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson’s Disease
Mitali A. Tambe, Aurélie de Rus Jacquet, Katherine E. Strathearn, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1463-1463
Open Access | Times Cited: 7
The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury
Lucia Machová Urdzíková, Veronika Cimermanova, Kristýna Kárová, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 363-363
Open Access | Times Cited: 6
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
A. M. Das, Swarnali Khan, Syamal Roy, et al.
(2023), pp. 336-376
Open Access | Times Cited: 6
Navigating α‐Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets
Maksym Galkin, Anastasiia Priss, Yevhenii Kyriukha, et al.
The Chemical Record (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 6
Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson’s Disease
Nitu Kumari, Santosh Anand, Kamal Shah, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7588-7588
Open Access | Times Cited: 6
Polyphenolic Compounds from Diet: Potential Role in Regulation of Gut Microbiota and Effects on Human Body
Sadhana Jadaun, Usha Sharma, Ringshangphi Khapudang, et al.
World sustainability series (2024), pp. 275-296
Closed Access | Times Cited: 1
Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
Xuxu Xu, Chaowei Han, Pengcheng Wang, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top